In recovery patients, restoration of immune cells count occurs with downregulation of NKG2A expression, which suggests that the progression of COVID-19 disease with cytotoxic lymphocytes exhaustion may result from upregulation of NKG2A in the early stage of COVID-19. The gene discussed is KLRC1; the disease is COVID-19.